Login

AMICUS THERAPEUTICS, INC. SEC Filings

Filed On Filing
12 Aug 2026 SCHEDULE 13G/A
14 May 2026 SCHEDULE 13G
11 May 2026 SCHEDULE 13G
07 May 2026 SCHEDULE 13G
07 May 2026 15-12G
01 May 2026 SCHEDULE 13G
29 Apr 2026 EFFECT
29 Apr 2026 EFFECT
29 Apr 2026 EFFECT
29 Apr 2026 EFFECT
29 Apr 2026 EFFECT
29 Apr 2026 EFFECT
29 Apr 2026 EFFECT
29 Apr 2026 EFFECT
29 Apr 2026 SCHEDULE 13G
27 Apr 2026 Form 4: Wheeler Craig A, Director

Returned 84,631 shares to the issuer ($1.23M) · Disposed of 313,630 Stock Options (right to buy) (Disposition to Issuer)

27 Apr 2026 Form 4: Mcglynn Margaret G, Director

Returned 94,631 shares to the issuer ($1.37M) · Disposed of 303,630 Stock Options (right to buy) (Disposition to Issuer)

27 Apr 2026 Form 4: Whitman Burke W, Director

Returned 118,598 shares to the issuer ($1.72M) · Disposed of 273,885 Stock Options (right to buy) (Disposition to Issuer)

27 Apr 2026 Form 4: Sblendorio Glenn, Director

Returned 142,564 shares to the issuer ($2.07M) · Disposed of 303,630 Stock Options (right to buy) (Disposition to Issuer)

27 Apr 2026 Form 4: Roberts Eiry, Director

Returned 76,275 shares to the issuer ($1.11M) · Disposed of 233,861 Stock Options (right to buy) (Disposition to Issuer)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support